| Pharmaceutical active ingredients: |
| Isosorbide Mononitrate |
| Available forms, composition and doses of Monolong Retard: |
| Capsules, Retard; Oral; Isosorbide Mononitrate |
| Monolong Retard medical category: |
| Human:Anti-anginal drugsNitrates and nitrites |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DA14 - Isosorbide Mononitrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| C.T.S. Chemical IndustriesAlpharmaLefnin |